Skip to main content
Premium Trial:

Request an Annual Quote

Bio-Rad Receives Notice From NYSE for Late Filing of Annual Report

NEW YORK (GenomeWeb) – Bio-Rad Laboratories said today that it has received an expected notice from the New York Stock Exchange about not complying with its listing requirements because it is late filing its annual report for fiscal year 2017 on Form 10-K with the US Securities and Exchange Commission.

The previously disclosed reason for the delay is that Bio-Rad's independent registered public accounting firm needs more time to complete its audit if the company's 2017 financial statements. This includes assessing the effectiveness of Bio-Rad's internal control over financial reporting related to its conversion to a new enterprise resource planning (ERP) system and business structure for a large portion of its European operations.

Bio-Rad said it intends to file its 2017 Form 10-K as soon as possible after the audit is complete.  

Under NYSE rules, Bio-Rad has six months from the due date to file the 2017 Form 10-K and will regain compliance with the listing standards when it does.

The Scan

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.

Acne-Linked Loci Found Through GWAS Meta-Analysis

Researchers in the European Journal of Human Genetics find new and known acne vulgaris risk loci with a genome-wide association study and meta-analysis, highlighting hair follicle- and metabolic disease-related genes.

Retina Cell Loss Reversed by Prime Editing in Mouse Model of Retinitis Pigmentosa

A team from China turns to prime editing to correct a retinitis pigmentosa-causing mutation in the PDE6b gene in a mouse model of the progressive photoreceptor loss condition in the Journal of Experimental Medicine.

CRISPR Screens Reveal Heart Attack-Linked Gene

Researchers in PLOS Genetics have used CRISPR screens to home in on variants associated with coronary artery disease that affect vascular endothelial function.